机构：[1]Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Dept Pathol, Beijing, Peoples R China[2]Peking Union Med Coll, Beijing, Peoples R China[3]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China[4]Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China四川大学华西医院[5]Hebei Med Univ, Hosp 4, Pathol, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院病理科医技科室[6]Soochow Univ, Affiliated Hosp, Suzhou, Peoples R China
第一作者机构：[1]Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Dept Pathol, Beijing, Peoples R China[2]Peking Union Med Coll, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Yuan P.,Li Y.,Jiang L.,et al.The Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients with Advanced Lung Adenocarcinoma[J].JOURNAL OF THORACIC ONCOLOGY.2018,13(10):S708-S709.doi:10.1016/j.jtho.2018.08.1169.
APA：
Yuan, P.,Li, Y.,Jiang, L.,Liu, Y.,Liu, W.&Ying, J..(2018).The Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients with Advanced Lung Adenocarcinoma.JOURNAL OF THORACIC ONCOLOGY,13,(10)
MLA：
Yuan, P.,et al."The Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients with Advanced Lung Adenocarcinoma".JOURNAL OF THORACIC ONCOLOGY 13..10(2018):S708-S709
医学